The article focuses on the treatment of membranoproliferative glomerulonephritis (MPGN). It informs that the MPGN is a pattern of injury caused by several diseases including nephrotic syndrome, hypertension and glomerular hematuria. It discusses that according to observational studies and randomised clinical trials (RCT), corticosteroid therapy is suggested for the treatment of MPGN in children.